IQV or IDXX: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Instruments stocks are likely familiar with IQVIA Holdings (IQV) and Idexx Laboratories (IDXX). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Feb 4, 2026

IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results

IDEXX Laboratories Inc. (NASDAQ: IDXX) reported better-than-expected fourth-quarter financial results and issued a fiscal 2026 forecast on Monday.

Benzinga • Feb 3, 2026

IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics

Animal diagnostics maker IDEXX Laboratories on Monday forecast 2026 revenue and profit above Wall Street estimates, betting that resilient demand at veterinary clinics and higher testing per visit will offset uneven clinic-visit trends.

Reuters • Feb 2, 2026

Idexx Laboratories Stock Topples Despite Its 'Impressive' Report

Idexx stock fell early Monday despite beating fourth-quarter expectations and issuing strong guidance for 2026.

Investors Business Daily • Feb 2, 2026

IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call Transcript

IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 2, 2026

IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results. Fourth Quarter and Full Year Results The Company reports revenues of $1,091 million for the fourth quarter of 2025, an increase of 14% compared to the prior year period as reported and 12% on an organic basis, driven by Companion Animal Group ("CAG") growth of 15% as reported and 13% organic and Water revenue growth of 12.

Business Wire • Feb 2, 2026

Idexx Laboratories (IDXX) Beats Q4 Earnings and Revenue Estimates

Idexx Laboratories (IDXX) came out with quarterly earnings of $3.08 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.62 per share a year ago.

Zacks Investment Research • Feb 2, 2026

Idexx (IDXX) Reports Q4 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Idexx (IDXX) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • Feb 2, 2026

IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise

IDXX tops Q4 EPS and revenue estimates as margins expand. However, shares dip during the pre-market trading, while 2026 guidance calls for steady growth.

Zacks Investment Research • Feb 2, 2026

3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)

Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research • Jan 29, 2026